Company Profile
VYNE Therapeutics Inc. Stock Price, News & Analysis
- Ticker:
- VYNE
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
28.56 USD (+12.22%)
Close
Last updated: July 27, 2026
22.5M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, VYNE closed up 12.2% at $28.56. No new same-company headline was identified in the current news window.
Company overview
Business overview
VYNE Therapeutics is a dermatology and immunology company focused on skin disease and inflammatory biology. Its story is built around developing specialized therapies for dermatologic conditions.
Geographic Base and Sector Classification
VYNE is headquartered in the United States and listed on NASDAQ. It sits in specialty dermatology biotechnology.
Business Model Characteristics
The company depends on clinical progress, formulation or mechanism differentiation, and capital efficiency. Investors typically watch data updates and the company's ability to sharpen its dermatology franchise.
Position Within the Biotechnology Landscape
VYNE occupies a focused dermatology niche within biotech. The stock is driven by whether its skin-disease programs can create durable differentiation.
Future catalysts
VYNE’s catalysts are dermatology and immunology programs, plus any update that shows the company can still keep the story alive. The stock remains early-stage and data-dependent.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
- 02
- 03
- 04
- 05
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
AVTX · Source: Avalo Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of VYNE Therapeutics Inc. (VYNE)?
VYNE Therapeutics Inc. (VYNE) most recently closed at 28.56 USD, a +12.22% move versus the previous session.
What is the market cap of VYNE Therapeutics Inc. (VYNE)?
VYNE Therapeutics Inc. currently has a market capitalization of 22.5M USD on BioPharmSignal.
What does VYNE Therapeutics Inc. do?
VYNE Therapeutics is a dermatology and immunology company focused on skin disease and inflammatory biology. Its story is built around developing specialized therapies for dermatologic conditions.
On which exchange is VYNE stock listed?
VYNE Therapeutics Inc. (VYNE) is associated with NASDAQ, United States, Biopharma.
What is Therapeutics?
VYNE Therapeutics is a dermatology and immunology company focused on skin disease and inflammatory biology.
Which conditions is VYNE Therapeutics Inc. targeting with Therapeutics?
VYNE Therapeutics Inc. is associated with immunology, dermatology based on its company overview and current catalyst commentary.
How does VYNE Therapeutics Inc. describe recent progress with Therapeutics?
VYNE’s catalysts are dermatology and immunology programs, plus any update that shows the company can still keep the story alive. The stock remains early-stage and data-dependent.
What future catalysts are investors watching for VYNE Therapeutics Inc.?
VYNE’s catalysts are dermatology and immunology programs, plus any update that shows the company can still keep the story alive. The stock remains early-stage and data-dependent.